Jones SF - Search Results

1

Open-Label, Multicenter, Phase I Study to Assess Safety and Tolerability of Adavosertib Plus Durvalumab in Patients with Advanced Solid Tumors.

Patel MR, Falchook GS, Wang JS, Imedio ER, Kumar S, Miah K, Mugundu GM, Jones SF, Spigel DR, Hamilton EP. Patel MR, et al. Among authors: jones sf. Target Oncol. 2024 Nov 19. doi: 10.1007/s11523-024-01110-8. Online ahead of print. Target Oncol. 2024. PMID: 39560862

2

Adavosertib in Combination with Olaparib in Patients with Refractory Solid Tumors: An Open-Label, Dose-Finding, and Dose-Expansion Phase Ib Trial.

Hamilton EP, Falchook GS, Wang JS, Fu S, Oza AM, Imedio ER, Kumar S, Ottesen L, Mugundu GM, de Bruin EC, O'Connor MJ, Jones SF, Spigel DR, Li BT. Hamilton EP, et al. Among authors: jones sf. Target Oncol. 2024 Nov;19(6):879-892. doi: 10.1007/s11523-024-01102-8. Epub 2024 Nov 1. Target Oncol. 2024. PMID: 39487373 Free PMC article. Clinical Trial.

3

Consensus-based framework for evaluating data modernization initiatives: the case of cancer registration and electronic reporting.

Subramanian S, Tangka FKL, Pordell P, Beizer J, Wilson R, Jones SF, Rogers JD, Benard VB, Richardson LC. Subramanian S, et al. Among authors: jones sf. JAMIA Open. 2023 Aug 23;6(3):ooad060. doi: 10.1093/jamiaopen/ooad060. eCollection 2023 Oct. JAMIA Open. 2023. PMID: 37638125 Free PMC article.

4

A Phase Ib Dose-Escalation Study of LCL161 Plus Oral Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies.

Johnson ML, Patel MR, Aljumaily R, Jones SF, Burris Iii HA, Spigel DR. Johnson ML, et al. Among authors: jones sf. Oncologist. 2023 Jul 5;28(7):640-e559. doi: 10.1093/oncolo/oyad029. Oncologist. 2023. PMID: 37129455 Free PMC article. Clinical Trial.

5

Operational Characteristics of Central Cancer Registries that Support the Generation of High-Quality Surveillance Data.

Edwards P, Bernacet A, Tangka FKL, Pordell P, Beizer J, Wilson R, Blumenthal W, Jones SF, Cole-Beebe M, Subramanian S. Edwards P, et al. Among authors: jones sf. J Registry Manag. 2022 Spring;49(1):10-16. J Registry Manag. 2022. PMID: 36968178 Free PMC article.

6

Discordance in Tumor Mutation Burden from Blood and Tissue Affects Association with Response to Immune Checkpoint Inhibition in Real-World Settings.

Sturgill EG, Misch A, Jones CC, Luckett D, Fu X, Schlauch D, Jones SF, Burris HA, Spigel DR, McKenzie AJ. Sturgill EG, et al. Among authors: jones sf. Oncologist. 2022 Mar 11;27(3):175-182. doi: 10.1093/oncolo/oyab064. Oncologist. 2022. PMID: 35274716 Free PMC article.

7

Tumor-Specific and Tumor-Agnostic Molecular Signatures Associated With Response to Immune Checkpoint Inhibitors.

Schlauch D, Fu X, Jones SF, Burris HA 3rd, Spigel DR, Reeves J, McKenzie AJ. Schlauch D, et al. Among authors: jones sf. JCO Precis Oncol. 2021 Nov;5:1625-1638. doi: 10.1200/PO.21.00008. JCO Precis Oncol. 2021. PMID: 34994650

8

Next-Generation Sequencing of Patients With Breast Cancer in Community Oncology Clinics.

Sturgill EG, Misch A, Lachs R, Jones CC, Schlauch D, Jones SF, Shastry M, Yardley DA, Burris HA 3rd, Spigel DR, Hamilton EP, McKenzie AJ. Sturgill EG, et al. Among authors: jones sf. JCO Precis Oncol. 2021 Nov;5:1297-1311. doi: 10.1200/PO.20.00469. JCO Precis Oncol. 2021. PMID: 34994634

9

Seasonal impoundment management reduces nitrogen cycling but not resilience to surface fire in a tidal wetland.

Jones SF, Schutte CA, Roberts BJ, Thorne KM. Jones SF, et al. J Environ Manage. 2022 Feb 1;303:114153. doi: 10.1016/j.jenvman.2021.114153. Epub 2021 Dec 4. J Environ Manage. 2022. PMID: 34875564

10

Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study.

Moore KN, Chambers SK, Hamilton EP, Chen LM, Oza AM, Ghamande SA, Konecny GE, Plaxe SC, Spitz DL, Geenen JJJ, Troso-Sandoval TA, Cragun JM, Rodrigo Imedio E, Kumar S, Mugundu GM, Lai Z, Chmielecki J, Jones SF, Spigel DR, Cadoo KA. Moore KN, et al. Among authors: jones sf. Clin Cancer Res. 2022 Jan 1;28(1):36-44. doi: 10.1158/1078-0432.CCR-21-0158. Epub 2021 Oct 13. Clin Cancer Res. 2022. PMID: 34645648

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters